#31Regional leaders 1–100

Octapharma

Switzerland · Switzerland

Vaccines and plasma productsPlasma, heparin and protein productsFinished dosage forms and small molecules

Manufacturing profile

Country
Switzerland
Regulatory region
Switzerland
ISO
CHE

Selection basis

The company is placed in positions 1–100 as a major regional manufacturer, biopharmaceutical group, important generics supplier or manufacturing/CDMO leader.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Biological inputs, cell culture or plasma pooling
  2. 2Purification, fractionation and viral-clearance stages
  3. 3Formulation and potency control
  4. 4Sterile filling or lyophilisation
  5. 5Sterility, endotoxin and cold-chain evidence
  6. 6Traceable biological raw-material intake
  7. 7Extraction, fractionation and multistep purification
  8. 8Viral safety and impurity removal
  9. 9Molecular-weight and potency analytics

Relevant FUZKK packages

Lumex — instrumental QC

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology